Armodacharge150 Mg (Armodafinil) Medically reviewed by Sanjay Gangani, B.Pharm, CMO & Pharmacist
Active Ingredient Armodafinil Indication Cognitive Enhancers Manufacturer Mednova Strength:- 150mg Packaging 10 tablet in 1 strip
INQUIRE ABOUT Armodacharge150 Mg (Armodafinil)
What is Armodacharge 150 Mg Armodacharge 150 is an oral tablet containing armodafinil 150 mg.
Armodafinil is a wakefulness-promoting medicine, also called a eugeroic.
It reduces excessive daytime sleepiness in specific diagnosed sleep disorders.
Armod 50 is the R-enantiomer of modafinil, the single active mirror image.
It is the active ingredient in the originator brand Nuvigil.
It is a prescription-only medicine everywhere it is approved.
It is not approved for chronic fatigue syndrome.
It is not approved for depression, ADHD or any mood disorder.
It is not approved for cognitive enhancement or studying.
It is not a nootropic or a “smart drug ” in any regulatory sense.
It is not a treatment for ordinary tiredness or poor sleep habits.
It does not treat the cause of sleep apnoea.
It is not a substitute for sleep.
Important point on obstructive sleep apnoea Armodafinil treats the sleepiness, not the blocked airway.
CPAP or other airway treatment must continue unchanged.
Stopping CPAP leaves the underlying apnoea untreated.
Untreated apnoea still raises blood pressure and cardiac risk.
Waklert 150 mg is approved by the FDA in the United States.
It is a Schedule IV controlled substance there.
It is not authorised in the European Union or the United Kingdom.
The European marketing application was withdrawn by the sponsor.
In those markets only modafinil is available, and only for narcolepsy.
In India it is a prescription-only medicine.
How It Works (Mechanism of Action) The precise mechanism is not fully established. The following actions are documented.
Armodafinil binds the dopamine transporter in the brain.
This blocks dopamine from being reabsorbed into nerve cells.
Extracellular dopamine therefore rises in wake-promoting pathways.
It activates orexin neurons in the lateral hypothalamus.
Orexin is the key signal that stabilises wakefulness.
It activates histamine neurons in the tuberomammillary nucleus.
Histamine release promotes cortical arousal.
Noradrenaline and glutamate levels rise in wake-related regions.
GABA, the main inhibitory transmitter, falls.
The net effect is sustained wakefulness without general stimulation.
How it differs from amphetamine-type stimulants Amphetamines force dopamine out of nerve cells in large amounts.
Armodafinil only slows dopamine reabsorption, and does so weakly.
Peripheral sympathetic effects are much smaller.
Rebound crash and rebound sleepiness are uncommon.
Abuse potential is lower, which is why it is Schedule IV not Schedule II.
It is not chemically related to amphetamine.
Modafinil is a mixture of two mirror-image molecules.
Armodafinil is only the R-form, which has a longer half-life.
Blood levels therefore stay higher later in the day.
Armodafinil 150 mg gives wakefulness roughly comparable to modafinil 200 mg.
The two are not interchangeable milligram for milligram.
Dosage Guide Approved adult dosing Indication Dose Timing Narcolepsy 150 mg or 250 mg once daily In the morning Obstructive sleep apnoea 150 mg or 250 mg once daily In the morning, alongside CPAP Shift work disorder 150 mg once daily About 1 hour before the shift starts Maximum daily dose 250 mg Doses above this give no added benefit
Missed dose & Overdose Take it as soon as you remember, but only early in the day.
Skip the dose entirely if it is already afternoon or evening.
A late dose will prevent sleep that night.
Never take two doses together.
Overdose causes insomnia, restlessness, agitation and confusion.
Tremor, palpitations, chest pain and raised blood pressure can occur.
Nausea, diarrhoea and anxiety are also reported.
There is no specific antidote.
Treatment is supportive, with cardiac monitoring.
Seek medical help immediately for any suspected overdose.
How to Take It Swallow the tablet whole with a glass of water.
Do not crush, chew or split it.
You may take it with or without food.
Food delays the onset by 2 to 4 hours, so be consistent.
For narcolepsy or sleep apnoea, take it in the morning.
For shift work, take it about 1 hour before the shift starts.
Never take it in the late afternoon or evening.
Continue your CPAP machine exactly as prescribed.
Avoid alcohol completely.
Limit caffeine, especially coffee and energy drinks.
Driving and operating machinery Do not assume this tablet makes you safe to drive.
Excessive sleepiness can persist despite treatment.
Judge your alertness honestly before driving.
Avoid driving until you know how the tablet affects you.
Dizziness and blurred vision are reported side effects.
Onset of wakefulness is usually within 1 to 2 hours.
The effect commonly lasts 10 to 14 hours.
It does not create energy. It removes the pressure to sleep.
It does not cure narcolepsy or sleep apnoea.
Tell your doctor if sleepiness is unchanged after 2 weeks.
Precautions Absolute Contraindications Do not take Armodacharge 150 if any of the following apply.
You are allergic to armodafinil or to modafinil.
You have had any serious rash caused by armodafinil or modafinil.
You have had a multi-organ hypersensitivity reaction to either drug.
You have had angioedema or anaphylaxis with either drug.
You are pregnant, or trying to become pregnant.
You have had stimulant-related heart changes with left ventricular hypertrophy.
You have mitral valve prolapse with previous stimulant-related symptoms.
The patient is under 18 years of age.
Conditions to Disclose to Your Doctor Tell your doctor before use if you have or have had any of the following.
Any heart disease, including angina or a previous heart attack
Any heart rhythm disorder or palpitations
Left ventricular hypertrophy or mitral valve prolapse
High blood pressure, controlled or not
Liver disease of any severity
Kidney disease
Psychosis, schizophrenia or any delusional illness
Mania, bipolar disorder or hypomania
Depression, or any history of suicidal thoughts
Severe anxiety or panic disorder
Epilepsy or seizures
Any history of drug, alcohol or stimulant misuse
Any previous drug rash or skin reaction
An eating disorder or unexplained weight loss
Pregnancy, planned pregnancy or breastfeeding
Also tell your doctor about every medicine you take, including:
Any hormonal contraceptive, including pill, patch, ring or implant
Blood thinners such as warfarin
Epilepsy medicines
Antidepressants and antipsychotics
Benzodiazepines and sleeping tablets
Heart and blood pressure medicines
Antifungals and antibiotics
HIV medicines
Ciclosporin or any transplant medicine
Herbal products
Any other stimulant, including modafinil
Food and Drink Precautions Item Advice Reason Food with the dose Be consistent, either always or never Food delays onset by 2 to 4 hours Water Drink normally through the day Dry mouth and thirst are common Caffeine, coffee and tea Limit strictly Additive anxiety, tremor and palpitations Energy drinks Avoid High caffeine plus stimulant effect Alcohol Avoid completely Unpredictable combination; masks sedation Grapefruit juice Avoid around the dose Inhibits CYP3A4 and may raise levels Other stimulant supplements Avoid Additive cardiovascular strain Large evening meals Avoid on dosing days Can delay the effect into the night
Before-Use Safety Checklist Confirm each point before taking a dose.
A doctor has diagnosed my sleep disorder formally.
A doctor has prescribed armodafinil for that diagnosis.
I have never had a rash or reaction to armodafinil or modafinil.
I am not pregnant and not trying to conceive.
If I use a hormonal contraceptive, I have arranged a backup method.
My doctor knows my heart and blood pressure history.
My doctor knows my mental health history.
My doctor knows my liver and kidney function.
I have told my doctor about every medicine I take.
I am not taking modafinil or any other stimulant.
I will take the dose in the morning, or before my shift.
I will continue my CPAP machine if I use one.
I know to stop the tablet at the first sign of any rash.
I will not drive until I know how it affects me.
The strip is sealed, undamaged and within its expiry date.
Side Effects Common side effects Side effect Frequency What to do Raised blood pressure Uncommon Monitor at home. Report high readings. Fast or irregular heartbeat Uncommon Stop and seek medical review. Chest pain Uncommon Stop and seek urgent care. Severe agitation or restlessness Uncommon Stop and contact your doctor. Depression, worsening Uncommon Seek medical help promptly. Suicidal thoughts Rare Medical emergency. Mania or hypomania Rare Medical emergency. Hallucinations or delusions Rare Medical emergency. Psychosis Rare Medical emergency. Aggression Rare Stop and seek medical review. Confusion Uncommon Stop and seek medical review. Dyskinesia or dystonia Rare Stop and contact your doctor. Seizure Rare Medical emergency. Vertigo or tinnitus Uncommon Report to your doctor. Blurred or abnormal vision Uncommon Report to your doctor. Raised liver enzymes Uncommon Blood test monitoring. Mouth ulcers Uncommon Report to your doctor. Vomiting or constipation Uncommon Report if persistent. Weight loss Uncommon Monitor and report. Raised blood lipids Uncommon Blood test monitoring. Low white cells or platelets Rare Blood test review. Raised eosinophils Rare May signal hypersensitivity. Report it. Itching, hives or urticaria Uncommon Stop and contact your doctor. Hair thinning Rare Report to your doctor. Psychological dependence Rare Discuss with your doctor. Angioedema Rare Medical emergency. Anaphylaxis Very rare Medical emergency. Stevens-Johnson syndrome Very rare Medical emergency. Toxic epidermal necrolysis Very rare Medical emergency. DRESS, multi-organ hypersensitivity Very rare Medical emergency.
The serious rash warning Armodafinil and modafinil can cause life-threatening skin reactions.
These include Stevens-Johnson syndrome and toxic epidermal necrolysis.
Most cases begin within the first 1 to 5 weeks of treatment.
Isolated later cases have also been reported.
There is no way to predict which rash will become serious.
Stop the tablet at the first sign of any rash and seek advice.
Do not wait to see whether it spreads.
The multi-organ hypersensitivity warning This reaction is also called DRESS syndrome.
It begins with fever and rash, often with swollen glands.
It then involves the liver, kidney, heart, lung or blood.
It can be fatal if the drug is continued.
Fever with rash on this medicine is a medical emergency.
Armodafinil is a Schedule IV controlled substance in the USA.
Euphoria and altered mood have been reported at higher doses.
Psychological dependence has been reported.
Use only the prescribed dose, for the prescribed indication.
Tell your doctor if you feel you need the tablet to function.
Drug Interactions – Avoid With Critical interaction: hormonal contraception Point Detail Mechanism Armodafinil induces CYP3A4 and speeds up hormone breakdown Effect Combined pills, progestogen pills, patches, rings and implants may fail Action Use an additional barrier method, or a non-hormonal method Duration Continue the backup for 1 month after stopping armodafinil Emergency contraception Standard doses may be less effective; seek advice Pregnancy risk Congenital malformations have been reported with these drugs
Armodafinil reduces the effect of these drugs (CYP3A4 induction) Drug or group Effect Combined and progestogen-only contraceptives Loss of contraceptive cover Ciclosporin Transplant rejection risk; levels fall Midazolam and triazolam Reduced sedative effect HIV protease inhibitors Reduced antiviral levels Some statins, including simvastatin and atorvastatin Reduced effect Some calcium channel blockers Reduced effect
Armodafinil increases the effect of these drugs (CYP2C19 inhibition) Drug or group Effect Diazepam Increased sedation Phenytoin Risk of phenytoin toxicity Propranolol Increased beta-blockade Omeprazole Raised levels Clomipramine and citalopram Raised levels; monitor for side effects Warfarin Monitor INR closely
Emergency Warning Signs Stop the medicine and get emergency medical help if any of these occur.
Any new rash, however mild it looks at first
Rash with blistering, peeling or raw patches
Sores in the mouth, eyes, nose or genitals
Rash with fever, swollen glands or feeling very unwell
Swelling of the lips, tongue, face or throat
Difficulty breathing, wheezing or hoarseness
Chest pain, pressure or tightness
Severe palpitations, or a very fast irregular pulse
Fainting or collapse
Hallucinations, hearing voices or fixed false beliefs
Severe agitation, mania or aggression
Any thought of harming yourself
A seizure
Yellowing of the skin or eyes, or very dark urine
Severe, unrelenting insomnia over several days
What to do about a rash Stop the tablet immediately. Do not take another dose.
Contact a doctor the same day, even for a mild rash.
Photograph the rash for the doctor.
Do not restart the tablet, even if the rash settles.
Tell every future prescriber about the reaction.
Why Choose This Medicine What armodafinil offers as a molecule:
Proven improvement in wakefulness in narcolepsy
Proven benefit for residual sleepiness in treated sleep apnoea
Proven benefit in shift work disorder
A longer half-life than the S-form found in modafinil
Higher blood levels later in the day, covering the afternoon dip
Once-daily dosing, with no need for a second afternoon dose
Much lower abuse potential than amphetamine-type stimulants
Few peripheral sympathomimetic effects such as marked tachycardia
Rebound sleepiness and a crash effect are uncommon
Does not suppress appetite as strongly as amphetamines
Well-characterised interaction profile
What to weigh before choosing it:
It is not authorised in the European Union or the United Kingdom.
It is a Schedule IV controlled substance in the United States.
It requires a formal sleep-disorder diagnosis, not self-assessment.
It treats sleepiness only, never the underlying cause.
CPAP must continue in sleep apnoea.
Serious skin and hypersensitivity reactions are rare but can be fatal.
It can cause hormonal contraception to fail.
It has no approved role in cognitive enhancement or study performance.
150 mg is the standard dose; higher doses add risk, not benefit.
Storage Instructions Store between 20 °C and 25 °C in a dry place.
Brief excursions between 15 °C and 30 °C are acceptable.
Keep the tablets in their original blister strip until use.
Protect from light, heat and moisture.
Do not store in a bathroom cabinet.
Do not refrigerate or freeze.
Keep out of the sight and reach of children.
Store securely; this is a controlled substance in some countries.
Do not use after the printed expiry date.
Do not use if the strip is torn, swollen or tampered with.
Do not use a tablet that is cracked, discoloured or crumbling.
Return unused or expired tablets to a pharmacy for disposal.
Do not flush them or put them in household waste.
Never share these tablets with another person.
Sanjay Gangani
B.Pharm, CMO & Pharmacist
Licensed pharmacist (B.Pharm) with 12+ years in clinical pharmacy and patient care. Reviews every article for evidence-based accuracy before it is published on ACTIZA Store.
Reviews
There are no reviews yet.